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FIRST CLINICAL CASE REPORTReport of the ﬁrst Vagococcus lutrae human infection, Marseille, FranceV. Garcia, C. Abat and J.-M. Rolain
Aix-Marseille University, URMITE UM 63 CNRS 7278 IRD 198 INSERM U1905, Méditerranée Infection, Facultés de Médecine et de Pharmacie, Marseille, FranceAbstractVagococcus lutrae is a Gram-positive coccus initially isolated from the common otter (Lutra lutra) but that has never been reported as a human
pathogen. We describe the ﬁrst case of human infection due to Vagococcus lutrae in Marseille, France.
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E-mail: jean-marc.rolain@univ-amu.frIntroductionVagococcus lutrae is a Gram-positive, catalase-negative, faculta-
tively anaerobic, motile coccus initially isolated and identiﬁed in
1999 from blood, liver, lungs and spleen samples from a common
otter (Lutra lutra) killed by a road trafﬁc accident on the Isle ofMull
in the United Kingdom [1]. Since then the bacterium has been
isolated from the intestine of a largemouth bass (Micropterus sal-
moides) caught in the wilds of Maine, USA [2]. However, this
bacterial species has never been isolated fromhumans.Weherein
report the ﬁrst human case of V. lutrae infection ever reported in
the world from a patient hospitalized in Marseille, France.Case reportA 58-year-old man was admitted to the intensive care unit of
Conception Hospital, Marseille, on 7 January 2015 for extensive
skin lesions after 4 months’ bed rest. The patient was morbidly
obese, with a body mass index of 41 kg/m2 (1 m 80 cm tall, weight
135 kg) and had experienced chronic depressive syndrome for 5w Microbe and New Infect 2016; 9: 56–57
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p://dx.doi.org/10.1016/j.nmni.2015.11.008years. At admission, the patient presentedwith skin lesions located
on the right side of his abdomen and on the right upper and lower
limbs. Skin lesions were erythematous, superﬁcial and covered
50% of his body surface (Fig. 1A). Skin lesions were probably
maceration lesions from prolonged bed rest and carelessness with
issuance of faeces and urine directly into the bed. At admission, the
patient was dehydrated, and his white blood cell count was high
(19.62 × 109/L). Blood cultures and skin biopsy samples were
collected while his lesions were being cleaned. After growth,
Vagococcus spp. was the only bacterium identiﬁed from the skin
biopsy samples by matrix-assisted laser desorption/ionization
time-of-ﬂight mass spectrometry (MALDI-TOF). 16S RNA stan-
dard PCR (99.9% sequence homology) indicated that the strains
belonged to the species V. lutrae. Antibiotic susceptibility testing
was undertaken and indicated that V. lutrae was susceptible to all
antibiotics tested, including amoxicillin, ceftriaxone, gentamicin,
erythromycin, rifampicin, clindamycin, doxycycline and vanco-
mycin. Dehydration was treated with insulin drip and glucose
solution. Skins lesions were cleaned and treated with dressings
containing sulfadiazine (Fig. 1B). V. lutrae infection was treated by
amoxicillin. After 15 days, the patient was considered cured.DiscussionV. lutrae is rarely isolated worldwide, which may be the result of
the ineffectiveness of conventional identiﬁcation methods. In
our setting, we routinely use MALDI-TOF technology for the
identiﬁcation of bacterial species isolated from clinical samplesEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
FIG. 1. Infected skin lesions due to Vagococcus lutrae. (A) Erythematous and infected skin lesions caused by V. lutrae. (B) Skin lesions healing after 10
days of treatment.
NMNI Garcia et al. V. lutrae skin infection 57[3]. As previously noted [4], this strategy allows us to consid-
erably increase our capacity to detect rare bacterial species,
including emerging pathogens. We accurately identiﬁed the
genus Vagococcus by MALDI-TOF, and the species was identi-
ﬁed by 16S RNA PCR.
In our case, we speculate that the infection originated from a
food-mediated acquisition of the pathogen, particularly through
ﬁsh and other seafood. Then, as a result of the patient’s poor
hygiene, the bacteriumwas excreted via the feces released directly
into his bed, leading to the patient’s skin infections, facilitated by
the maceration lesions resulting from his prolonged bed rest.
All together, our observations allowed us to correctly
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